Susquehanna International Group
TPST icon

Susquehanna International Group’s Tempest Therapeutics TPST Stock Holding History

Susquehanna International Group’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-25,800
Closed -$175K – 13903
2025
Q2 		$175K Buy
25,800
+21,646
+521% +$154K ﹤0.01% 11348
2025
Q1 		$40K Sell
4,154
-2,331
-36% -$26.4K ﹤0.01% 11928
2024
Q4 		$70K Buy
6,485
+2,277
+54% +$29.4K ﹤0.01% 11539
2024
Q3 		$76.6K Buy
+4,208
New +$86.2K ﹤0.01% 11194
2024
Q1 		– Sell
-2,231
Closed -$128K – 13338
2023
Q4 		$128K Buy
+2,231
New +$106K ﹤0.01% 11125
2021
Q4 		– Sell
-1,954
Closed -$368K – 13920
2021
Q3 		$368K Sell
1,954
-146
-7% -$28.4K ﹤0.01% 10119
2021
Q2 		$305K Buy
2,100
+2,047
+3,862% +$460K ﹤0.01% 10740
2021
Q1 		$12K Buy
+53
New +$21.4K ﹤0.01% 12153
2020
Q4 		– Sell
-84
Closed -$27K – 11747
2020
Q3 		$27K Buy
84
+15
+22% +$5.09K ﹤0.01% 10349
2020
Q2 		$24K Sell
69
-2,957
-98% -$1.18M ﹤0.01% 9900
2020
Q1 		$3.12M Buy
+3,026
New +$4.41M ﹤0.01% 3229
2016
Q4 		– Sell
-11
Closed -$230K – 10163
2016
Q3 		$230K Sell
11
-1
-8% -$18.1K ﹤0.01% 7362
2016
Q2 		$187K Sell
12
-5
-29% -$114K ﹤0.01% 7653
2016
Q1 		$478K Sell
17
-4
-19% -$84.5K ﹤0.01% 6481
2015
Q4 		$605K Sell
21
-19
-48% -$627K ﹤0.01% 6406
2015
Q3 		$1M Sell
40
-12
-23% -$808K ﹤0.01% 5750
2015
Q2 		$4.39M Buy
52
+39
+300% +$3.57M ﹤0.01% 3131
2015
Q1 		$1.35M Buy
+13
New +$1.73M ﹤0.01% 5147

Other funds holding TPST

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Belvedere Trading
Belvedere Trading Chicago, Illinois $84.4B AUM 52.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Susquehanna International Group's TPST Position: Q2 2025 in Review

Susquehanna International Group sold out of Tempest Therapeutics (TPST) in Q2 2025, closing a stake of 8,812 shares — an estimated $62.6K sold.

Susquehanna International Group first reported a position in TPST in Q2 2013 and held it in 21 quarters. The position peaked at $3.1M in Q2 2015. 18 funds tracked by Wall St. Rank hold TPST as of Q2 2025.

  • Susquehanna International Group reported no remaining Tempest Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Susquehanna International Group sold 8,812 Tempest Therapeutics shares in Q2 2025, an estimated $62.6K.
  • Susquehanna International Group first reported a position in Tempest Therapeutics in Q2 2013 and held it in 21 quarters.
  • Susquehanna International Group's Tempest Therapeutics position peaked at $3.1M in Q2 2015.
  • 18 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.